Advertisement

Clinical & Experimental Metastasis

, Volume 30, Issue 8, pp 1019–1031 | Cite as

Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells

  • Suman Sengupta
  • Samir Jana
  • Subir Biswas
  • Palash Kumar Mandal
  • Arindam Bhattacharyya
Research Paper

Abstract

Epithelial to mesenchymal transition (EMT) is a secondary phenomenon concomitantly associated with the tumor progression. The regulatory signals and mechanistic details of EMT are not fully elucidated. Here, we shared a TGF-β mediated mechanism of EMT in breast cancer (MDA-MB 231) cells. Initial exposure of TGF-β for 48 h, enhanced the rate of cell proliferation and associated with EMT of MDA-MB 231 cells. The EMT was characterized by observing the increased N-cadherin, fibronectin, Snail expression and associated with the morphological change with a reduced E-cadherin expression. NFAT, a transcription factor, alters tumor suppressive function of TGF-β towards tumor progression. Up regulation of NFAT, coupled with a foremost translocation of one oncogenic protein SnoN from cytoplasm to nucleus was noticed during this TGF-β mediated EMT. Silencing of NFAT also showed the inhibition of TGF-β mediated EMT characterized by down regulation of N-cadherin and associated with reduced expression of SnoN. In addition, it was also observed that NFAT sequestering the Smad3 prevents the proteasome mediated degradation of SnoN and this SnoN has a role on the regulation of MMP-2, MMP-9 activity. Increased Smad3-SnoN interaction and proteasome mediated degradation of SnoN were detected after silencing of NFAT with a reduced MMP-2, MMP-9 activity. All of these observations provide a fresh mechanism in which by a twofold involvement of NFAT and SnoN plays a crucial role in TGF-β mediated EMT by recruiting the effector molecules N-cadherin and MMP-2, MMP-9.

Keywords

TGF-β NFAT SnoN Breast cancer EMT 

Notes

Acknowledgments

Authors want to thank Department of Biotechnology and Department of NanoScience, University of Calcutta, respectively for Fluorescence Microscopy and Bio imaging instrument facility. Authors also want to specially thank Subhadip Kundu, Soham Mitra and Tarun Keswani for their support during the experiments. This work was supported by grants from Department of Biotechnology (DBT/PR 9779/27/67/2007), Government of India and Indian Council of Medical Research (Immuno/18/11/21/2002-ECD-1) India and DST FIST and UGC-SAP.

Conflict of interest

The authors have no conflict of interest.

Supplementary material

10585_2013_9600_MOESM1_ESM.tif (573 kb)
TGF-β continues EMT on MDA-MB 231 cells for 48 h of treatment on higher concentration. (a) Phase contrast micrograph (at 20X magnification) of MDA-MB231 cells treated with TGF-β according to respective the concentration for 48 h. (b) RT-PCR represents the gene expression of Fibronectin and Snail after 48 h treatment of TGF-β at respective conc. GAPDH expression was used for loading control. Bar graph represents the quantitative densitometry value of the expressed gene and the data represent the mean ± SE of three independent experiments

References

  1. 1.
    de Caestecker MP, Piek E, Roberts AB (2000) Role of transforming growth factor-β signaling in cancer. J Natl Cancer Inst 92(17):1388–1402PubMedCrossRefGoogle Scholar
  2. 2.
    Knabbe C, Kopp A, Hilgers W, Lang D, Muller V, Zugmaier G, Jonat W (1996) Regulation and role of TGF-β production in breast cancer. Ann N Y Acad Sci 784:263–276PubMedCrossRefGoogle Scholar
  3. 3.
    Muraoka-Cook RS, Dumont N, Arteaga CL (2005) Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin Cancer Res 11:937s–943sPubMedGoogle Scholar
  4. 4.
    Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425:577–584PubMedCrossRefGoogle Scholar
  5. 5.
    Boyer PL, Colmenares C, Stavnezer E, Hughes SH (1993) Sequence and biological activity of chicken SnoN cDNA clones. Oncogene 8:457–466PubMedGoogle Scholar
  6. 6.
    Kang Yibin (2006) Pro-metastasis function of TGF-β mediated by the Smad pathway. J Cell Biochem 98:1380–1390PubMedCrossRefGoogle Scholar
  7. 7.
    Oft M, Heider KH, Beug H (1998) TGF-β signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8:1243–1252PubMedCrossRefGoogle Scholar
  8. 8.
    Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E (1996) TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10:2462–2477PubMedCrossRefGoogle Scholar
  9. 9.
    Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890PubMedCrossRefGoogle Scholar
  10. 10.
    Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764–5774PubMedCrossRefGoogle Scholar
  11. 11.
    Nomura N, Sasamoto S, Ishii S, Date T, Matsui M, Ishizaki R (1989) Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res 17:5489–5500PubMedCrossRefGoogle Scholar
  12. 12.
    Singh G, Singh SK, König A, Reutlinger K, Nye MD, Adhikary T, Eilers M, Gress TM, Fernandez-Zapico ME, Ellenrieder V (2010) Sequential activation of NFAT and c-MYC transcription factors mediates the TGF-β switch from a suppressor to a promoter of cancer cell proliferation. J Biol Chem 285(35):27241–27250 http://www.jbc.org/cgi/doi/10.1074/jbc.M110.100438 Google Scholar
  13. 13.
    Pearson-White S, Crittenden R (1997) Proto-oncogene SnoN expression, alternative isoforms and immediate early serum response. Nucleic Acids Res 25:2930–2937PubMedCrossRefGoogle Scholar
  14. 14.
    Imoto I, Pimkhaokham A, Fukuda Y, Yang ZQ, Shimada Y, Nomura N, Hirai H, Imamura M, Inazawa J (2001) SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 286:559–565PubMedCrossRefGoogle Scholar
  15. 15.
    Pearson-White S (1993) SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res 21:4632–4638PubMedCrossRefGoogle Scholar
  16. 16.
    Zhang F, Lundin M, Ristimaki A, Heikkila P, Lundin J, Isola J, Joensuu H, Laiho M (2003) Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-β signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 63:5005–5010PubMedGoogle Scholar
  17. 17.
    Jakowlew SB (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435–457PubMedCrossRefGoogle Scholar
  18. 18.
    Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377PubMedCrossRefGoogle Scholar
  19. 19.
    Zhonghua kou, Qiang Yi Xue Za Zhi (2011) Expression of transforming growth factor-β (1) and Ki-67 nuclear antigen in salivary gland mucoepidermoid carcinoma. [Article in Chinese] 46(1):20–3Google Scholar
  20. 20.
    Bates RC, Mercurio AM (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4:365–370PubMedCrossRefGoogle Scholar
  21. 21.
    Bates RC, Pursell BM, Mercurio AM (2007) Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells. Cells Tissues Organs 185:29–39PubMedCrossRefGoogle Scholar
  22. 22.
    Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA et al (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213:374–383PubMedCrossRefGoogle Scholar
  23. 23.
    Miyazono K (2009) Transforming growth factor-beta signaling in epithelial mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 85:314–323PubMedCrossRefGoogle Scholar
  24. 24.
    Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715PubMedCrossRefGoogle Scholar
  25. 25.
    Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3:e2888PubMedCrossRefGoogle Scholar
  26. 26.
    Liu X, Sun Y, Weinberg RA, Lodish HF (2001) Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev 12(1):121–128CrossRefGoogle Scholar
  27. 27.
    Luo K (2004) Ski and SnoN: negative regulators of TGF-β signaling. Curr Opin Genet Dev 14:65–70PubMedCrossRefGoogle Scholar
  28. 28.
    Zhu Q, Pearson-White S, Luo K (2005) Requirement for the SnoN Oncoprotein in transforming growth factor-β induced oncogenic transformation of fibroblast cells. Mol Cell Biol 25(24):10731–10744. doi: 10.1128/MCB.25.24 PubMedCrossRefGoogle Scholar
  29. 29.
    Pelzer T, Lyons GE, Kim S, Moreadith RW (1996) Cloning and characterization of the murine homolog of the sno proto-oncogene reveal a novel splice variant. Dev Dyn 205:114–125PubMedCrossRefGoogle Scholar
  30. 30.
    Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K, Wrana JL (2001) TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3:587–595PubMedCrossRefGoogle Scholar
  31. 31.
    Stroschein SL, Bonni S, Wrana JL, Luo K (2001) Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 15:2822–2836PubMedGoogle Scholar
  32. 32.
    Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K (1999) Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286:771–774PubMedCrossRefGoogle Scholar
  33. 33.
    Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA Jr, Meltzer PS, Hahn SA, Kern SE (1996) DPC4 gene in various tumor types. Cancer Res 56:2527–2530PubMedGoogle Scholar
  34. 34.
    Padua D, Massague J (2009) Roles of TGF-β in metastasis. Cell Res 19:89–102PubMedCrossRefGoogle Scholar
  35. 35.
    Wakefield LM, Roberts AB (2002) TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12:22–29PubMedCrossRefGoogle Scholar
  36. 36.
    Bhowmick NA, Ghiassi M, Bakin A et al (2001) TGF-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27–36PubMedCrossRefGoogle Scholar
  37. 37.
    Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779–790PubMedCrossRefGoogle Scholar
  38. 38.
    Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13:7003–7011PubMedCrossRefGoogle Scholar
  39. 39.
    Pyo SW, Hashimoto M, Kim YS et al (2007) Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 35:1–9PubMedCrossRefGoogle Scholar
  40. 40.
    Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279PubMedCrossRefGoogle Scholar
  41. 41.
    Comijn J, Berx G, Vermassen P et al (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7:1267–1278PubMedCrossRefGoogle Scholar
  42. 42.
    Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 9(7):415–428CrossRefGoogle Scholar
  43. 43.
    Cano A, Perez-Moreno MA, Rodrigo I et al (2000) The transcription factor snail controls epithelial mesenchymal Transitions by repressing E-cadherin expression. Nat Cell Biol 2:76–83PubMedCrossRefGoogle Scholar
  44. 44.
    Nagata M, Goto K, Ehata S et al (2006) Nuclear and cytoplasmic c-Ski differently modulate cellular functions. Genes Cells 11:1267–1280PubMedCrossRefGoogle Scholar
  45. 45.
    Oft M, Akhurst RJ, Balmain A (2002) Metastasis are driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4(7):487–494PubMedCrossRefGoogle Scholar
  46. 46.
    Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A (2005) TGF-β and the Smad signaling pathway support Transcriptomic Reprogramming during Epithelial-Mesenchymal cell Transition. Mol Biol Cell 16:1987–2002PubMedCrossRefGoogle Scholar
  47. 47.
    Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA (1999) SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor-β signaling. Proc Natl Acad Sci USA 96:12442–12447PubMedCrossRefGoogle Scholar
  48. 48.
    Zhu Q, Krakowski AR, Ariel R, Dunham EE, Bandyopadhyay A, Berdeaux R, Martin GS, Sun L, Luo K (2007) Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 27:324–339PubMedCrossRefGoogle Scholar
  49. 49.
    Duivenvoorden WC, Hirte HW, Singh G (1999) TGF-β1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin Exp Metastasis 17:27–34PubMedCrossRefGoogle Scholar
  50. 50.
    Kim ES, Sohn YW, Moon A (2007) TGF-β-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF) 2 in human breast epithelial cells. Cancer Lett 252:147–156PubMedCrossRefGoogle Scholar
  51. 51.
    Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481–490PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Suman Sengupta
    • 1
    • 2
  • Samir Jana
    • 1
  • Subir Biswas
    • 1
  • Palash Kumar Mandal
    • 3
  • Arindam Bhattacharyya
    • 1
  1. 1.Immunology Lab, Department of ZoologyUniversity of CalcuttaKolkataIndia
  2. 2.Department of Environmental ScienceUniversity of KalyaniKalyaniIndia
  3. 3.Department of PathologyMedical College KolkataKolkataIndia

Personalised recommendations